3 Lesser-Known Healthcare Names With Major Upside in Store These are three healthcare stocks offering a compelling combination of secure business, strong fundamentals, and growth opportunity. MarketBeat · Oct 2, 2025
Recap Of Monday's Biotech Catalysts - End Of the Day Summary The U.S. Food and Drug Administration (FDA) has announced clearance to Insulet’s (NASDAQ:PODD) Omnipod 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged two years and older with type 1 diabetes (T1D). Insulet shares traded in a range of $260.13 to $266.73 on day volume of 200.86 thousand shares… Benzinga · Aug 22, 2022